News

Temozolomide Partially Effective for Aggressive Pituitary Tumors, But More Study Needed, Case Report Shows

Temozolomide — an oral chemotherapy treatment — may be partially effective for Cushing’s disease patients with aggressive pituitary tumors that do not respond to conventional therapies, a case report suggests. However, despite initial tumor stabilization with temozolomide treatment, the patient described in the case report died shortly thereafter, indicating a…

Adrenal Crisis Not a Major Cause of Death in Cushing’s Patients with Adrenal Insufficiency

Cushing’s syndrome patients who have adrenal insufficiency have increased risk of death due to disease-related complications, rather than adrenal crisis or adverse occurrences, an observational study suggests. The study, “Mortality data from the European Adrenal Insufficiency Registry—Patient characterization and associations,” was published in the journal Clinical…